Όλο το DSpace

Πλοήγηση ανά Θέμα "Vital Capacity"

Αποτελέσματα 1-4 από 4

    • Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis 

      Karampitsakos T., Torrisi S., Antoniou K., Manali E., Korbila I., Papaioannou O., Sampsonas F., Katsaras M., Vasarmidi E., Papakosta D., Domvri K., Fouka E., Organtzis I., Daniil Z., Dimeas I., Kirgou P., Gourgoulianis K.I., Papanikolaou I.C., Markopoulou K., Kounti G., Tsapakidou E., Papadopoulou E., Tatsis K., Gogali A., Kostikas K., Tzilas V., Chrysikos S., Papiris S., Bouros D., Kreuter M., Tzouvelekis A. (2021)
      Background: Idiopathic Pulmonary Fibrosis (IPF) represents a chronic lung disease with unpredictable course. Methods: We aimed to investigate prognostic performance of complete blood count parameters in IPF. Treatment-naïve ...

    • The pharmacological cost of COPD during greek economic crisis 

      Stafyla E., Kerenidi T., Gerogianni I., Geitona M., Daniil Z., Gourgoulianis K.I. (2017)
      Introduction: The economic crisis in Greece has substantially affected patients with COPD. The reduction of disposable income has its consequences on patients’ ability to afford their medication. The aim of the study is ...

    • Pulmonary function testing in COPD: looking beyond the curtain of FEV1 

      Kakavas S., Kotsiou O.S., Perlikos F., Mermiri M., Mavrovounis G., Gourgoulianis K., Pantazopoulos I. (2021)
      Chronic obstructive pulmonary disease (COPD) management remains challenging due to the high heterogeneity of clinical symptoms and the complex pathophysiological basis of the disease. Airflow limitation, diagnosed by ...

    • Underestimation of respiratory symptoms by smokers: a thorn in chronic obstructive pulmonary disease diagnosis 

      Gogou E., Kotsiou O.S., Siachpazidou D.S., Pinaka M., Varsamas C., Bardaka F., Gerogianni I., Hatzoglou C., Gourgoulianis K.I. (2021)
      Primary care centers are ideal positions to identify chronic obstructive pulmonary disease (COPD). We determined the COPD prevalence among ever-smokers aged 40–65 years attending a 2-year program conducted in 22 Greek ...